Addus HomeCare (NASDAQ:ADUS) Earns “Outperform” Rating from Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a report published on Thursday,Benzinga reports. The brokerage currently has a $136.00 price target on the stock.

A number of other equities research analysts have also issued reports on ADUS. Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Finally, TD Cowen upped their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Price Performance

Shares of ADUS opened at $119.78 on Thursday. The firm’s 50 day moving average is $128.99 and its 200-day moving average is $122.42. Addus HomeCare has a 12-month low of $85.43 and a 12-month high of $136.12. The stock has a market capitalization of $2.17 billion, a P/E ratio of 27.41, a P/E/G ratio of 2.15 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the firm posted $1.03 earnings per share. As a group, equities research analysts forecast that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total transaction of $63,750.00. Following the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 12.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 22,917 shares of company stock worth $3,050,082. 4.60% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in ADUS. BNP Paribas Financial Markets lifted its stake in shares of Addus HomeCare by 20.3% in the first quarter. BNP Paribas Financial Markets now owns 11,854 shares of the company’s stock worth $1,225,000 after buying an additional 2,000 shares during the last quarter. Empowered Funds LLC boosted its holdings in Addus HomeCare by 9.8% during the first quarter. Empowered Funds LLC now owns 6,890 shares of the company’s stock valued at $712,000 after acquiring an additional 615 shares during the period. Russell Investments Group Ltd. grew its position in shares of Addus HomeCare by 9.3% in the first quarter. Russell Investments Group Ltd. now owns 46,764 shares of the company’s stock valued at $4,833,000 after purchasing an additional 3,997 shares during the last quarter. ProShare Advisors LLC increased its stake in shares of Addus HomeCare by 7.3% in the first quarter. ProShare Advisors LLC now owns 3,163 shares of the company’s stock worth $327,000 after purchasing an additional 214 shares during the period. Finally, Entropy Technologies LP acquired a new position in shares of Addus HomeCare during the 1st quarter worth about $258,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.